OMEICOS THERAPEUTICS

OMEICOS Therapeutics is developing a novel, first-in-class, small molecule utilizing a new Mode of Action. OMEICOS' novel therapeutic strategy is based upon the discovery of natural metabolites of omega-3 fatty acids that mediate a strong anti-arrhythmic effect. In contrast to all other anti-arrhythmic drugs, OMEICOS' substances activate an endogenous cardio-protective signaling pathway that not only stabilizes the heart rhythm but shall provide curative effects to the diseased organ by preventing its electrical and structural remodeling.

#SimilarOrganizations #People #Financial #Website #More

OMEICOS THERAPEUTICS

Social Links:

Linkedin

Twitter

Industry:

Health Care Medical Therapeutics

Founded:

2013-01-01

Address:

Berlin, Berlin, Germany

Country:

Germany

Website Url:

http://www.omeicos.com

Total Employee:

11+

Status:

Active

Contact:

+49 (0)30 9489 4810

Email Addresses:

[email protected]

Total Funding:

37.31 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon WordPress AJAX Libraries API WordPress 5.8 DFN

Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

heartbeat-medical-logo

heartbeat medical

Heartbeat collects the most important data point in healthcare: quality of life (PROMs) and turns it into Real World Evidence (RWE)

interline-therapeutics-logo

Interline Therapeutics

Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.

viking-therapeutics-logo

Viking Therapeutics

Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.

Current Advisors List

christian-schetter_image

Christian Schetter Independent Board Member @ OMEICOS Therapeutics
Board_member
2019-02-01

Current Employees Featured

robert-fischer_image

Robert Fischer
Robert Fischer Founder, CEO and Chief Scientific Officer @ OMEICOS Therapeutics
Founder, CEO and Chief Scientific Officer
2013-06-01

karen-uhlmann_image

Karen Uhlmann
Karen Uhlmann Vice President Operations & IP @ OMEICOS Therapeutics
Vice President Operations & IP
2020-08-01

alexander-gebauer_image

Alexander Gebauer
Alexander Gebauer Managing Director @ OMEICOS Therapeutics
Managing Director

Founder

karen-uhlmann_image

Karen Uhlmann

robert-fischer_image

Robert Fischer

Investors List

the-falck-revocable-trust_image

The Falck Revocable Trust

The Falck Revocable Trust investment in Series C - OMEICOS Therapeutics

kg-investments_image

KG Investments

KG Investments investment in Series C - OMEICOS Therapeutics

vc-fonds-technologie-berlin_image

VC Fonds Technologie Berlin

VC Fonds Technologie Berlin investment in Series C - OMEICOS Therapeutics

forbion-capital-partners_image

Forbion Capital Partners

Forbion Capital Partners investment in Series C - OMEICOS Therapeutics

smsgroup_image

SMSgroup

SMSgroup investment in Series C - OMEICOS Therapeutics

remiges-ventures_image

Remiges Ventures

Remiges Ventures investment in Series C - OMEICOS Therapeutics

sicar_image

SICAR

SICAR investment in Series C - OMEICOS Therapeutics

high-tech-gründerfonds_image

High-Tech Grunderfonds

High-Tech Grunderfonds investment in Series C - OMEICOS Therapeutics

kfw_image

KfW

KfW investment in Series C - OMEICOS Therapeutics

vesalius-biocapital-partners_image

Vesalius Biocapital Partners

Vesalius Biocapital Partners investment in Series C - OMEICOS Therapeutics

Official Site Inspections

http://www.omeicos.com

Host Informations
Whois Informations

Loading ...

More informations about "OMEICOS Therapeutics" on Search Engine